TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10946810
log Bayes Factor = 36.9069
Chromosome 6   position 26,288,055  (GRCh37) Explore rs10946810 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.008 0.992
K90 Intestinal malabsorption
0.000 0.542 0.457
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.597 0.403
K90.3 Pancreatic steatorrhoea
0.000 0.672 0.328
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.672 0.328
K90.1 Tropical sprue
0.000 0.672 0.328
K90.9 Intestinal malabsorption, unspecified
0.000 0.708 0.292
K90.8 Other intestinal malabsorption
0.000 0.760 0.240
I10 Essential (primary) hypertension
0.000 0.803 0.197
E83 Disorders of mineral metabolism
0.000 0.895 0.105
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.925 0.075
E83.8 Other disorders of mineral metabolism
0.000 0.925 0.075
E83.2 Disorders of zinc metabolism
0.000 0.925 0.075
E83.0 Disorders of copper metabolism
0.000 0.925 0.075
E83.3 Disorders of phosphorus metabolism
0.000 0.928 0.072
C85.1 B-cell lymphoma, unspecified
0.000 0.955 0.045
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.957 0.043
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.958 0.042
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.958 0.042
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.958 0.042
C83.3 Large cell (diffuse)
0.000 0.958 0.042
C81 Hodgkin's disease
0.000 0.961 0.039
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.961 0.039
C83.7 Burkitt's tumour
0.000 0.962 0.038
C82.2 Large cell, follicular
0.000 0.963 0.037
I10-I15 Hypertensive diseases
0.000 0.964 0.036
E83.4 Disorders of magnesium metabolism
0.000 0.964 0.036
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.964 0.036
C82.0 Small cleaved cell, follicular
0.000 0.965 0.035
C93 Monocytic leukaemia
0.000 0.965 0.035
K90-K93 Other diseases of the digestive system
0.000 0.966 0.034
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.966 0.034
C81.0 Lymphocytic predominance
0.000 0.967 0.033
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.967 0.033
C88 Malignant immunoproliferative diseases
0.000 0.967 0.033
C83.1 Small cleaved cell (diffuse)
0.000 0.967 0.032
C81.1 Nodular sclerosis
0.000 0.968 0.032
C81.9 Hodgkin's disease, unspecified
0.000 0.969 0.031
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.969 0.031
C85.0 Lymphosarcoma
0.000 0.969 0.031
C82.4 Follicular lymphoma grade IIIb
0.000 0.969 0.031
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.969 0.031
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.969 0.031
C83.6 Undifferentiated (diffuse)
0.000 0.969 0.030
C83.5 Lymphoblastic (diffuse)
0.000 0.969 0.030
C83.4 Immunoblastic (diffuse)
0.000 0.969 0.030
C83.2 Mixed small and large cell (diffuse)
0.000 0.969 0.030
C82.6 Cutaneous follicle centre lymphoma
0.000 0.969 0.030
C82.5 Diffuse follicle centre lymphoma
0.000 0.969 0.030
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.970 0.030
C94 Other leukaemias of specified cell type
0.000 0.970 0.030
C93.1 Chronic monocytic leukaemia
0.000 0.970 0.030
C86 Other specified types of T/NK-cell lymphoma
0.000 0.972 0.028
C82.3 Follicular lymphoma grade IIIa
0.000 0.972 0.028
C81.7 Other Hodgkin's disease
0.000 0.972 0.028
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.972 0.028
C81.3 Lymphocytic depletion
0.000 0.972 0.028
C81.2 Mixed cellularity
0.000 0.972 0.028
C95 Leukaemia of unspecified cell type
0.000 0.972 0.028
I11 Hypertensive heart disease
0.000 0.972 0.028
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.972 0.028
I13 Hypertensive heart and renal disease
0.000 0.974 0.026
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.974 0.026
E83.5 Disorders of calcium metabolism
0.000 0.974 0.025
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.975 0.025
C93.9 Monocytic leukaemia, unspecified
0.000 0.975 0.025
C93.7 Other monocytic leukaemia
0.000 0.975 0.025
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.975 0.025
C93.2 Subacute monocytic leukaemia
0.000 0.975 0.025
C93.0 Acute monocytic leukaemia
0.000 0.975 0.025
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.975 0.024
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.976 0.024
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.976 0.023
C88.7 Other malignant immunoproliferative diseases
0.000 0.976 0.023
C88.3 Immunoproliferative small intestinal disease
0.000 0.976 0.023
C88.2 Gamma heavy chain disease
0.000 0.976 0.023
C88.1 Alpha heavy chain disease
0.000 0.976 0.023
C94.7 Other specified leukaemias
0.000 0.978 0.022
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.978 0.022
C94.5 Acute myelofibrosis
0.000 0.978 0.022
C94.4 Acute panmyelosis
0.000 0.978 0.022
C94.3 Mast cell leukaemia
0.000 0.978 0.022
C94.2 Acute megakaryoblastic leukaemia
0.000 0.978 0.022
C94.1 Chronic erythraemia
0.000 0.978 0.022
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.978 0.022
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.978 0.022
C96.8 Histiocytic sarcoma
0.000 0.978 0.022
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.978 0.022
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.978 0.022
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.978 0.022
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.978 0.022
C96.3 True histiocytic lymphoma
0.000 0.978 0.022
C96.2 Malignant mast cell tumour
0.000 0.978 0.022
C96.1 Malignant histiocytosis
0.000 0.978 0.022
C96.0 Letterer-Siwe disease
0.000 0.978 0.022
I15 Secondary hypertension
0.000 0.979 0.021
E11 Non-insulin-dependent diabetes mellitus
0.000 0.979 0.021
C92 Myeloid leukaemia
0.000 0.979 0.021
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.979 0.020
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.979 0.020
C86.4 Blastic NK-cell lymphoma
0.000 0.979 0.020
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.979 0.020
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.979 0.020
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.979 0.020
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.979 0.020
C95.7 Other leukaemia of unspecified cell type
0.000 0.980 0.020
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.980 0.020
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.980 0.020
C95.0 Acute leukaemia of unspecified cell type
0.000 0.980 0.020
E11.2 With renal complications
0.000 0.980 0.020
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.980 0.020
C83.0 Small cell (diffuse)
0.000 0.980 0.019
E11.5 With peripheral circulatory complications
0.000 0.981 0.019
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.981 0.019
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.981 0.019
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.981 0.019
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.981 0.019
E11.4 With neurological complications
0.000 0.981 0.019
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.981 0.019
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.981 0.019
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.981 0.019
C84.3 Lymphoepithelioid lymphoma
0.000 0.981 0.019
C84.2 T-zone lymphoma
0.000 0.981 0.019
C84.1 Sezary's diease
0.000 0.981 0.019
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.981 0.018
C84.0 Mycosis fungoides
0.000 0.982 0.018
E11.6 With other specified complications
0.000 0.982 0.018
C95.9 Leukaemia, unspecified
0.000 0.982 0.018
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.982 0.018
K93.1 Megacolon in Chagas' disease
0.000 0.982 0.018
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.982 0.018
E16.2 Hypoglycaemia, unspecified
0.000 0.982 0.018
E11.9 Without complications
0.000 0.983 0.017
E10-E14 Diabetes mellitus
0.000 0.983 0.017
C84.5 Other and unspecified T-cell lymphomas
0.000 0.983 0.017
C84.4 Peripheral T-cell lymphoma
0.000 0.983 0.017
H57 Other disorders of eye and adnexa
0.016 0.984 0.000
I15.9 Seconday hypertension, unspecified
0.000 0.984 0.016
H57.8 Other specified disorders of eye and adnexa
0.016 0.984 0.000
E11.0 With coma
0.000 0.984 0.016
I15.8 Other secondary hypertension
0.000 0.985 0.015
I15.2 Hypertension secondary to endocrine disorders
0.000 0.985 0.015
E11.7 With multiple complications
0.000 0.985 0.015
H57.9 Disorder of eye and adnexa, unspecified
0.015 0.985 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.985 0.015
C92.7 Other myeloid leukaemia
0.000 0.985 0.015
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.985 0.015
C92.5 Acute myelomonocytic leukaemia
0.000 0.985 0.015
C92.3 Myeloid sarcoma
0.000 0.985 0.015
C92.2 Subacute myeloid leukaemia
0.000 0.985 0.015
H57.0 Anomalies of pupillary function
0.015 0.985 0.000
E11.1 With ketoacidosis
0.000 0.985 0.015
E14 Unspecified diabetes mellitus
0.000 0.985 0.015
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.986 0.014
E16 Other disorders of pancreatic internal secretion
0.000 0.986 0.014
I15.0 Renovascular hypertension
0.000 0.986 0.014
H57.1 Ocular pain
0.014 0.986 0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.000 0.986 0.014
C92.9 Myeloid leukaemia, unspecified
0.000 0.986 0.014
E14.3 With ophthalmic complications
0.000 0.986 0.014
C92.4 Acute promyelocytic leukaemia
0.000 0.986 0.014
C92.1 Chronic myeloid leukaemia
0.000 0.986 0.014
E11.3 With ophthalmic complications
0.000 0.987 0.013
E11.8 With unspecified complications
0.000 0.987 0.013
E14.1 With ketoacidosis
0.000 0.987 0.013
E10 Insulin-dependent diabetes mellitus
0.000 0.987 0.013
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.987 0.013
E14.5 With peripheral circulatory complications
0.000 0.987 0.013
E14.6 With other specified complications
0.000 0.987 0.012
E12 Malnutrition-related diabetes mellitus
0.000 0.987 0.012
M65.9 Synovitis and tenosynovitis, unspecified
0.000 0.988 0.012
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.000 0.988 0.012
E10.5 With peripheral circulatory complications
0.000 0.988 0.012
C92.0 Acute myeloid leukaemia
0.000 0.988 0.012
E10.0 With coma
0.000 0.988 0.012
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.988 0.012
E70-E90 Metabolic disorders
0.000 0.988 0.012
C90.2 Plasmacytoma, extramedullary
0.000 0.989 0.011
E13 Other specified diabetes mellitus
0.000 0.989 0.011
I15.1 Hypertension secondary to other renal disorders
0.000 0.989 0.011
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.000 0.989 0.011
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.989 0.011
E14.7 With multiple complications
0.000 0.989 0.011
E14.0 With coma
0.000 0.989 0.011
E14.8 With unspecified complications
0.000 0.989 0.011
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.989 0.010
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.989 0.010
E16.4 Abnormal secretion of gastrin
0.000 0.989 0.010
E16.3 Increased secretion of glucagon
0.000 0.989 0.010
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.000 0.989 0.011
I12 Hypertensive renal disease
0.000 0.989 0.010
E40-E46 Malnutrition
0.000 0.990 0.010
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.990 0.010
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.990 0.010
E16.1 Other hypoglycaemia
0.000 0.990 0.010
E10.3 With ophthalmic complications
0.000 0.990 0.010
C90.1 Plasma cell leukaemia
0.000 0.990 0.010
N18.3 Chronic kidney disease, stage 3
0.000 0.990 0.010
K70.0 Alcoholic fatty liver
0.000 0.990 0.010
E10.1 With ketoacidosis
0.000 0.990 0.010
K70.4 Alcoholic hepatic failure
0.000 0.990 0.010
E10.8 With unspecified complications
0.000 0.990 0.009
E10.7 With multiple complications
0.000 0.990 0.009
E15 Nondiabetic hypoglycaemic coma
0.000 0.990 0.009
E80.4 Gilbert's syndrome
0.000 0.991 0.009
K70 Alcoholic liver disease
0.000 0.991 0.009
K70.9 Alcoholic liver disease, unspecified
0.000 0.991 0.009
E14.4 With neurological complications
0.000 0.991 0.009
E73 Lactose intolerance
0.000 0.991 0.009
E46 Unspecified protein-energy malnutrition
0.000 0.991 0.009
E12.9 Without complications
0.000 0.991 0.009
E12.8 With unspecified complications
0.000 0.991 0.009
E12.7 With multiple complications
0.000 0.991 0.009
E12.6 With other specified complications
0.000 0.991 0.009
E12.5 With peripheral circulatory complications
0.000 0.991 0.009
E12.4 With neurological complications
0.000 0.991 0.009
E12.3 With ophthalmic complications
0.000 0.991 0.009
E12.2 With renal complications
0.000 0.991 0.009
E12.1 With ketoacidosis
0.000 0.991 0.009
E12.0 With coma
0.000 0.991 0.009
E88 Other metabolic disorders
0.000 0.991 0.009
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.000 0.991 0.009
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.000 0.991 0.009
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.000 0.991 0.009
E84 Cystic fibrosis
0.000 0.991 0.009
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.000 0.991 0.009
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.991 0.009
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.991 0.009
C91 Lymphoid leukaemia
0.000 0.991 0.008
E77 Disorders of glycoprotein metabolism
0.000 0.991 0.009
E76 Disorders of glycosaminoglycan metabolism
0.000 0.991 0.009
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.991 0.009
E70 Disorders of aromatic amino-acid metabolism
0.000 0.991 0.009
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.991 0.009
E79 Disorders of purine and pyrimidine metabolism
0.000 0.991 0.009
E14.2 Withrenal complications
0.000 0.992 0.008
C90.3 Solitary plasmacytoma
0.000 0.992 0.008
E13.8 With unspecified complications
0.000 0.992 0.008
E13.7 With multiple complications
0.000 0.992 0.008
E13.6 With other specified complications
0.000 0.992 0.008
E13.5 With peripheral circulatory complications
0.000 0.992 0.008
E13.4 With neurological complications
0.000 0.992 0.008
E13.3 With ophthalmic complications
0.000 0.992 0.008
E13.2 With renal complications
0.000 0.992 0.008
E13.1 With ketoacidosis
0.000 0.992 0.008
E13.0 With coma
0.000 0.992 0.008
E10.6 With other specified complications
0.000 0.992 0.008
Z75.1 Person awaiting admission to adequate facility elsewhere
0.000 0.992 0.008
E80.2 Other porphyria
0.000 0.992 0.008
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.000 0.992 0.008
E73.9 Lactose intolerance, unspecified
0.000 0.992 0.008
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.992 0.008
E45 Retarded development following protein-energy malnutrition
0.000 0.992 0.008
E43 Unspecified severe protein-energy malnutrition
0.000 0.992 0.008
E42 Marasmic kwashiorkor
0.000 0.992 0.008
E41 Nutritional marasmus
0.000 0.992 0.008
E40 Kwashiorkor
0.000 0.992 0.008
E88.8 Other specified metabolic disorders
0.000 0.992 0.008
E72 Other disorders of amino-acid metabolism
0.000 0.992 0.007
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.992 0.007
E80.5 Crigler-Najjar syndrome
0.000 0.992 0.007
E80.3 Defects of catalase and peroxydase
0.000 0.992 0.007
E80.1 Porphyria cutanea tarda
0.000 0.992 0.007
E80.0 Hereditary erythropoietic porphyria
0.000 0.992 0.007
E10.4 With neurological complications
0.000 0.992 0.008
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.993 0.007
K70.3 Alcoholic cirrhosis of liver
0.000 0.993 0.007
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.993 0.007
E74 Other disorders of carbohydrate metabolism
0.000 0.993 0.007
E10.2 With renal complications
0.000 0.993 0.007
E73.8 Other lactose intolerance
0.000 0.993 0.007
E73.1 Secondary lactase deficiency
0.000 0.993 0.007
E73.0 Congenital lactase deficiency
0.000 0.993 0.007
E84.9 Cystic fibrosis, unspecified
0.000 0.993 0.007
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.993 0.007
E13.9 Without complications
0.000 0.993 0.007
E88.9 Metabolic disorder, unspecified
0.000 0.993 0.007
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.993 0.007
D45 Polycythaemia vera
0.000 0.993 0.007
E75.5 Other lipid storage disorders
0.000 0.993 0.007
E84.8 Cystic fibrosis with other manifestations
0.000 0.993 0.007
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.993 0.007
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.993 0.007
E88.3 Tumour lysis syndrome
0.000 0.993 0.007
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.993 0.007
M65 Synovitis and tenosynovitis
0.000 0.993 0.007
E75.6 Lipid storage disorder, unspecified
0.000 0.993 0.006
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.993 0.006
E75.3 Sphingolipidosis, unspecified
0.000 0.993 0.006
E75.2 Other sphingolipidosis
0.000 0.993 0.006
E75.1 Other gangliosidosis
0.000 0.993 0.006
E75.0 GM2 gangliosidosis
0.000 0.993 0.006
E80.6 Other disorders of bilirubin metabolism
0.000 0.993 0.006
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.993 0.006
C91.7 Other lymphoid leukaemia
0.000 0.993 0.006
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.993 0.006
C91.3 Prolymphocytic leukaemia
0.000 0.993 0.006
C91.2 Subacute lymphocytic leukaemia
0.000 0.993 0.006
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.993 0.006
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.993 0.006
E70.3 Albinism
0.000 0.993 0.006
E70.2 Disorders of tyrosine metabolism
0.000 0.993 0.006
E70.1 Other hyperphenylalaninaemias
0.000 0.993 0.006
E70.0 Classical phenylketonuria
0.000 0.993 0.006
E71.3 Disorders of fatty-acid metabolism
0.000 0.993 0.006
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.993 0.006
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.993 0.006
E71.0 Maple-syrup-urine disease
0.000 0.993 0.006
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.993 0.006
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.993 0.006
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.993 0.006
E76.2 Other mucopolysaccharidoses
0.000 0.993 0.006
E76.1 Mucopolysaccharidosis, type II
0.000 0.993 0.006
E76.0 Mucopolysaccharidosis, type I
0.000 0.993 0.006
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.993 0.006
E77.8 Other disorders of glycoprotein metabolism
0.000 0.993 0.006
E77.1 Defects in glycoprotein degradation
0.000 0.993 0.006
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.993 0.006
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.993 0.006
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.993 0.006
E79.1 Lesch-Nyhan syndrome
0.000 0.993 0.006
H55-H59 Other disorders of eye and adnexa
0.006 0.994 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.994 0.006
C91.9 Lymphoid leukaemia, unspecified
0.000 0.994 0.006
K70.1 Alcoholic hepatitis
0.000 0.994 0.006
E65-E68 Obesity and other hyperalimentation
0.000 0.994 0.006
E88.2 Lipomatosis, not elsewhere classified
0.000 0.994 0.006
N85.0 Endometrial glandular hyperplasia
0.006 0.994 0.000
C91.5 Adult T-cell leukaemia
0.000 0.994 0.006
D36.7 Other specified sites
0.000 0.994 0.006
K91.5 Postcholecystectomy syndrome
0.000 0.994 0.006
K91.1 Postgastric surgery syndromes
0.000 0.994 0.006
E44.1 Mild protein-energy malnutrition
0.000 0.994 0.006
E44.0 Moderate protein-energy malnutrition
0.000 0.994 0.006
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
0.006 0.994 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.994 0.005
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.994 0.005
E72.5 Disorders of glycine metabolism
0.000 0.994 0.005
E72.4 Disorders of ornithine metabolism
0.000 0.994 0.005
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.994 0.005
E72.2 Disorders of urea cycle metabolism
0.000 0.994 0.005
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.994 0.005
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.994 0.006
D36.1 Peripheral nerves and autonomic nervous system
0.000 0.994 0.006
E20-E35 Disorders of other endocrine glands
0.000 0.994 0.006
C22.1 Intrahepatic bile duct carcinoma
0.000 0.994 0.006
Z86.7 Personal history of diseases of the circulatory system
0.000 0.994 0.006
C91.0 Acute lymphoblastic leukaemia
0.000 0.995 0.005
M65.4 Radial styloid tenosynovitis [de Quervain]
0.000 0.995 0.005
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.995 0.005
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.995 0.005
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.995 0.005
E74.2 Disorders of galactose metabolism
0.000 0.995 0.005
E74.1 Disorders of fructose metabolism
0.000 0.995 0.005
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.000 0.995 0.005
Z43.1 Attention to gastrostomy
0.000 0.995 0.005
K91.4 Colostomy and enterostomy malfunction
0.000 0.995 0.005
C22.9 Liver, unspecified
0.000 0.995 0.005
H59.8 Other postprocedural disorders of eye and adnexa
0.005 0.995 0.000
E65 Localised adiposity
0.000 0.995 0.005
M65.2 Calcific tendinitis
0.000 0.995 0.005
M65.0 Abscess of tendon sheath
0.000 0.995 0.005
E74.0 Glycogen storage disease
0.000 0.995 0.005
E34 Other endocrine disorders
0.000 0.995 0.005
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.000 0.995 0.005
E34.9 Endocrine disorder, unspecified
0.000 0.995 0.005
M65.8 Other synovitis and tenosynovitis
0.000 0.995 0.005
D36 Benign neoplasm of other and unspecified sites
0.000 0.995 0.005
M65.1 Other infective (teno)synovitis
0.000 0.995 0.005
E27 Other disorders of adrenal gland
0.000 0.995 0.005
E72.0 Disorders of amino-acid transport
0.000 0.995 0.004
E67 Other hyperalimentation
0.000 0.995 0.005
E68 Sequelae of hyperalimentation
0.000 0.995 0.005
E06.3 Autoimmune thyroiditis
0.000 0.995 0.005
I12.9 Hypertensive renal disease without renal failure
0.000 0.995 0.005
C64 Malignant neoplasm of kidney, except renal pelvis
0.000 0.995 0.005
E85 Amyloidosis
0.000 0.995 0.004
H59.0 Vitreous syndrome following cataract surgery
0.005 0.995 0.000
E29 Testicular dysfunction
0.000 0.995 0.005
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)
0.000 0.995 0.005
E00-E07 Disorders of thyroid gland
0.000 0.995 0.005
D47.3 Essential (haemorrhagic) thrombocythaemia
0.000 0.995 0.005
C22.0 Liver cell carcinoma
0.000 0.995 0.005
E26 Hyperaldosteronism
0.000 0.996 0.004
E25 Adrenogenital disorders
0.000 0.996 0.004
E20 Hypoparathyroidism
0.000 0.996 0.004
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.996 0.004
H59.9 Postprocedural disorder of eye and adnexa, unspecified
0.004 0.996 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.996 0.004
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.996 0.004
E32 Diseases of thymus
0.000 0.996 0.004
E31 Polyglandular dysfunction
0.000 0.996 0.004
E30 Disorders of puberty, not elsewhere classified
0.000 0.996 0.004
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.996 0.004
H55 Nystagmus and other irregular eye movements
0.004 0.996 0.000
H72.0 Central perforation of tympanic membrane
0.004 0.996 0.000
E27.1 Primary adrenocortical insufficiency
0.000 0.996 0.004
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.996 0.004
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.996 0.004
E06 Thyroiditis
0.000 0.996 0.004
E03 Other hypothyroidism
0.000 0.996 0.004
G59.0 Diabetic mononeuropathy
0.000 0.996 0.004
M65.84 Other synovitis and tenosynovitis (Hand)
0.000 0.996 0.004
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec
0.000 0.996 0.004
M65.48 Radial styloid tenosynovitis [de Quervain]-Other
0.000 0.996 0.004
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot
0.000 0.996 0.004
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg
0.000 0.996 0.004
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh
0.000 0.996 0.004
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm
0.000 0.996 0.004
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region
0.000 0.996 0.004
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)
0.000 0.996 0.004
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.996 0.004
E29.1 Testicular hypofunction
0.000 0.996 0.004
M65.86 Other synovitis and tenosynovitis (Lower leg)
0.000 0.996 0.004
D36.0 Lymph nodes
0.000 0.996 0.004
E34.8 Other specified endocrine disorders
0.000 0.996 0.004
M65.3 Trigger finger
0.000 0.996 0.004
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)
0.000 0.996 0.004
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm
0.000 0.996 0.004
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.000 0.996 0.004
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.996 0.004
R40.0 Somnolence
0.004 0.996 0.000
D47.2 Monoclonal gammopathy
0.000 0.996 0.004
E27.2 Addisonian crisis
0.000 0.996 0.004
M65.09 Abscess of tendon sheath (Site unspecified)
0.000 0.996 0.004
M65.08 Abscess of tendon sheath (Other)
0.000 0.996 0.004
M65.07 Abscess of tendon sheath (Ankle and foot)
0.000 0.996 0.004
M65.06 Abscess of tendon sheath (Lower leg)
0.000 0.996 0.004
M65.05 Abscess of tendon sheath (Pelvic region and thigh)
0.000 0.996 0.004
M65.04 Abscess of tendon sheath (Hand)
0.000 0.996 0.004
M65.03 Abscess of tendon sheath (Forearm)
0.000 0.996 0.004
M65.02 Abscess of tendon sheath (Upper arm)
0.000 0.996 0.004
M65.01 Abscess of tendon sheath (Shoulder region)
0.000 0.996 0.004
M65.00 Abscess of tendon sheath (Multiple sites)
0.000 0.996 0.004
M65.29 Calcific tendinitis (Site unspecified)
0.000 0.996 0.004
M65.28 Calcific tendinitis (Other)
0.000 0.996 0.004
M65.27 Calcific tendinitis (Ankle and foot)
0.000 0.996 0.004
M65.26 Calcific tendinitis (Lower leg)
0.000 0.996 0.004
M65.25 Calcific tendinitis (Pelvic region and thigh)
0.000 0.996 0.004
M65.24 Calcific tendinitis (Hand)
0.000 0.996 0.004
M65.23 Calcific tendinitis (Forearm)
0.000 0.996 0.004
M65.22 Calcific tendinitis (Upper arm)
0.000 0.996 0.004
M65.21 Calcific tendinitis (Shoulder region)
0.000 0.996 0.004
M65.20 Calcific tendinitis (Multiple sites)
0.000 0.996 0.004
H58 Other disorders of eye and adnexa in diseases classified elsewhere
0.004 0.996 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.996 0.004
E27.8 Other specified disorders of adrenal gland
0.000 0.996 0.004
E34.5 Androgen resistance syndrome
0.000 0.996 0.004
E34.4 Constitutional tall stature
0.000 0.996 0.004
E34.3 Short stature, not elsewhere classified
0.000 0.996 0.004
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.996 0.004
E34.1 Other hypersecretion of intestinal hormones
0.000 0.996 0.004
C22.7 Other specified carcinomas of liver
0.000 0.996 0.004
C22.4 Other sarcomas of liver
0.000 0.996 0.004
C22.3 Angiosarcoma of liver
0.000 0.996 0.004
C22.2 Hepatoblastoma
0.000 0.996 0.004
M65.89 Other synovitis and tenosynovitis (Site unspecified)
0.000 0.996 0.004
M65.88 Other synovitis and tenosynovitis (Other)
0.000 0.996 0.004
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)
0.000 0.996 0.004
M65.82 Other synovitis and tenosynovitis (Upper arm)
0.000 0.996 0.004
M65.80 Other synovitis and tenosynovitis (Multiple sites)
0.000 0.996 0.004
C91.4 Hairy-cell leukaemia
0.001 0.996 0.003
M65.81 Other synovitis and tenosynovitis (Shoulder region)
0.000 0.996 0.004
M65.19 Other infective (teno)synovitis (Site unspecified)
0.000 0.996 0.004
M65.18 Other infective (teno)synovitis (Other)
0.000 0.996 0.004
M65.17 Other infective (teno)synovitis (Ankle and foot)
0.000 0.996 0.004
M65.16 Other infective (teno)synovitis (Lower leg)
0.000 0.996 0.004
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)
0.000 0.996 0.004
M65.13 Other infective (teno)synovitis (Forearm)
0.000 0.996 0.004
M65.12 Other infective (teno)synovitis (Upper arm)
0.000 0.996 0.004
M65.11 Other infective (teno)synovitis (Shoulder region)
0.000 0.996 0.004
M65.10 Other infective (teno)synovitis (Multiple sites)
0.000 0.996 0.004
E27.5 Adrenomedullary hyperfunction
0.000 0.996 0.004
E27.0 Other adrenocortical overactivity
0.000 0.996 0.004
D03.3 Melanoma in situ of other and unspecified parts of face
0.000 0.996 0.004
D05.9 Carcinoma in situ of breast, unspecified
0.004 0.996 0.000
A49.8 Other bacterial infections of unspecified site
0.000 0.996 0.004
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.996 0.004
E67.8 Other specified hyperalimentation
0.000 0.996 0.003
E67.3 Hypervitaminosis D
0.000 0.996 0.003
E67.2 Megavitamin-B6 syndrome
0.000 0.996 0.003
E67.1 Hypercarotenaemia
0.000 0.996 0.003
E67.0 Hypervitaminosis A
0.000 0.996 0.003
E14.9 Without complications
0.000 0.996 0.004
D39.1 Ovary
0.000 0.996 0.004
E85.8 Other amyloidosis
0.000 0.996 0.003
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.996 0.003
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.996 0.003
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.996 0.003
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.000 0.996 0.004
E10.9 Without complications
0.000 0.996 0.004
E29.8 Other testicular dysfunction
0.000 0.996 0.003
E29.0 Testicular hyperfunction
0.000 0.996 0.003
K91.3 Postoperative intestinal obstruction
0.000 0.996 0.004
E26.9 Hyperaldosteronism, unspecified
0.000 0.996 0.003
N43.3 Hydrocele, unspecified
0.004 0.996 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.996 0.003
E00 Congenital iodine-deficiency syndrome
0.000 0.996 0.003
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.996 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.